WPD Pharmaceuticals Aktie - WBIO

Rendering Error

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Current Price

0,07

Gebot

0,06

Fragen

0,19

Volumen

0,00 Tagesbereich 0,00

0,07 52-Wochen-Bereich 1,125

Handelsende

0,07

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

251

Finanzvolumen

VWAP

WPD Pharmaceuticals Provides Update On Berubicin Drug Candidate in Celebration of National Brain Cancer Day in Canada

VANCOUVER, British Columbia, Oct. 26, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE:...

WPD Pharmaceuticals Appoints New Chief Medical Officer to Lead Phase I and II Clinic Trials

VANCOUVER, British Columbia, Oct. 15, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE:...

WPD Pharmaceuticals Receives the First Prepayment of $705,000 from Total $7.4 Million Grant for Development of Berubicin, and...

VANCOUVER, British Columbia, Oct. 05, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE:...

WPD Pharmaceuticals Receives Second Prepayment of $705,000 from Total $7.4 Million Grant for Development of WPD101

VANCOUVER, British Columbia, Sept. 16, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE:...

WPD Pharmaceuticals Engages Worldwide Clinical Trials as CRO for Phase 2 Berubicin Trials

VANCOUVER, British Columbia, Sept. 09, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (“WPD” or the...

WPD Pharmaceuticals Announces New Publication Demonstrating Highly Effective Anticancer Therapy in Animals with Spontaneous T...

VANCOUVER, British Columbia, Sept. 01, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (“WPD” or the...

WPD Pharmaceuticals Enters into Collaborative Agreement for WP1122, Receives Supply and Appoints New CFO

VANCOUVER, British Columbia, Aug. 17, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (“WPD” or the...

WPD Pharmaceuticals Provides Update on WPD101, a Drug Candidate Targeting GBM Tumors

VANCOUVER, British Columbia, July 28, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (“WPD” or the...

WPD Pharmaceuticals Licensor Announces New Independent In Vitro Testing Confirms Antiviral Activity of WP1122 in Coronavirus

VANCOUVER, British Columbia, July 23, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE:...

WPD Pharmaceuticals Licensor Announces Updates on Annamycin and WP1066

VANCOUVER, British Columbia, July 06, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE:...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0.07	0.07	0.07	32	0.07	CS
4	0	0	0.07	0.07	0.07	8	0.07	CS
12	-0.055	-44	0.125	0.19	0.07	251	0.12313573	CS
26	-0.055	-44	0.125	0.5	0.07	13370	0.14549154	CS
52	-1.055	-93.7777777778	1.125	1.125	0.07	28923	0.18816961	CS
156	-1.305	-94.9090909091	1.375	1.875	0.07	9759	0.20826064	CS
260	-18.68	-99.6266666667	18.75	36.5	0.07	31119	10.34785328	CS

WBIO - Frequently Asked Questions (FAQ)

What is the current WPD Pharmaceuticals share price?

The current share price of WPD Pharmaceuticals is $ 0,07

What is the 1 year trading range for WPD Pharmaceuticals share price?

WPD Pharmaceuticals has traded in the range of $ 0,07 to $ 1,125 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
FUTRGold n Futures Mineral Corp	$ 0,01 (100,00%)	17,56k
PDFIProphecy DeFi Inc	$ 0,01 (100,00%)	39k
CATCAT Strategic Metals Corporation	$ 0,01 (100,00%)	247k
XTRXAdastra Holdings Ltd	$ 0,46 (58,62%)	500
NIRVNirvana Life Sciences Inc	$ 0,15 (50,00%)	2,5k
LTHMChampion Electric Metals Inc	$ 0,005 (-50,00%)	7,08M
FFNT4Front Ventures Corp	$ 0,015 (-40,00%)	9k
GLDSGolden Spike Resources Corp	$ 0,025 (-28,57%)	1,43M
AITTTrenchant Technologies Capital Corp	$ 0,07 (-26,32%)	81k
TGIITrojan Gold Inc	$ 0,015 (-25,00%)	9k
LTHMChampion Electric Metals Inc	$ 0,005 (-50,00%)	7,08M
QIMCQuebec Innovative Materials Corp	$ 0,245 (0,00%)	2,13M
SOLSOL Global Investments Corp	$ 0,09 (-14,29%)	1,99M
CACRKWG Resources Inc	$ 0,035 (0,00%)	1,74M
GLDSGolden Spike Resources Corp	$ 0,025 (-28,57%)	1,43M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

WPD Pharmaceuticals Inc (WBIO)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

WBIO Neueste Nachrichten

WPD Pharmaceuticals Provides Update On Berubicin Drug Candidate in Celebration of National Brain Cancer Day in Canada

WPD Pharmaceuticals Appoints New Chief Medical Officer to Lead Phase I and II Clinic Trials

WPD Pharmaceuticals Receives the First Prepayment of $705,000 from Total $7.4 Million Grant for Development of Berubicin, and...

WPD Pharmaceuticals Receives Second Prepayment of $705,000 from Total $7.4 Million Grant for Development of WPD101

WPD Pharmaceuticals Engages Worldwide Clinical Trials as CRO for Phase 2 Berubicin Trials

WPD Pharmaceuticals Announces New Publication Demonstrating Highly Effective Anticancer Therapy in Animals with Spontaneous T...

WPD Pharmaceuticals Enters into Collaborative Agreement for WP1122, Receives Supply and Appoints New CFO

WPD Pharmaceuticals Provides Update on WPD101, a Drug Candidate Targeting GBM Tumors

WPD Pharmaceuticals Licensor Announces New Independent In Vitro Testing Confirms Antiviral Activity of WP1122 in Coronavirus

WPD Pharmaceuticals Licensor Announces Updates on Annamycin and WP1066

WBIO - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

WPD Pharmaceuticals Inc (WBIO) Börsenkurse

WPD Pharmaceuticals Inc (WBIO)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

WBIO Neueste Nachrichten

WPD Pharmaceuticals Provides Update On Berubicin Drug Candidate in Celebration of National Brain Cancer Day in Canada

WPD Pharmaceuticals Appoints New Chief Medical Officer to Lead Phase I and II Clinic Trials

WPD Pharmaceuticals Receives the First Prepayment of $705,000 from Total $7.4 Million Grant for Development of Berubicin, and...

WPD Pharmaceuticals Receives Second Prepayment of $705,000 from Total $7.4 Million Grant for Development of WPD101

WPD Pharmaceuticals Engages Worldwide Clinical Trials as CRO for Phase 2 Berubicin Trials

WPD Pharmaceuticals Announces New Publication Demonstrating Highly Effective Anticancer Therapy in Animals with Spontaneous T...

WPD Pharmaceuticals Enters into Collaborative Agreement for WP1122, Receives Supply and Appoints New CFO

WPD Pharmaceuticals Provides Update on WPD101, a Drug Candidate Targeting GBM Tumors

WPD Pharmaceuticals Licensor Announces New Independent In Vitro Testing Confirms Antiviral Activity of WP1122 in Coronavirus

WPD Pharmaceuticals Licensor Announces Updates on Annamycin and WP1066

WBIO - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen